At SOMAÍ, we are building a leading global brand with the most robust pipeline of innovative cannabis-based therapeutics. We envision a world where people live a healthy lifestyle empowered by natural cannabis medicine.
SOMAÍ owns a state-of-the-art manufacturing facility and indoor cultivation in Lisbon, Portugal, and has global sales teams in the largest medical cannabis markets. We are continuing to make acquisitions and global brand partnerships that make us one of a few and the first European-based vertically integrated companies in the EU able to cater to the diverse needs of fast-growing global cannabis markets.
Thailand is already the largest global medical cannabis market, with $1.2 billion in local sales. But that’s not all — Thailand…
Read moreDan Herer, son of the legendary Jack Herer, partners with Somai Pharmaceuticals to take the Herer standard worldwide. Blending grassroots…
Read moreThe global medical cannabis markets are growing faster than we could have predicted, and new countries are expected to come…
Read moreMichael Sassano, CEO of Somai Pharmaceuticals, discusses global cannabis expansion, navigating regulations, and the future of cannabis products. Discover how…
Read moreThe Jack Herer Brand, an iconic U.S.-based cannabis company, has announced a strategic partnership with SOMAÍ, a leading EU-GMP-certified vertically…
Read moreA New Era for Medical Cannabis: SOMAÍ Teams Up with Iconic California Brands SHERBINSKIS and BOUTIQ for Europe and Australia…
Read moreAccess to safe and controlled cannabis for the Irish people is being decided upon in 2025. Watching a country make…
Read more2025 has kicked off fast and furious for the global cannabis industry as volumes increase and more countries come online…
Read moreMulti-state operators, or MSO’s, have long represented the biggest and most influential cannabis players in North America. Yet, as that…
Read moreFor years, medical cannabis has been treated as a commodity, with little emphasis on brand differentiation. However, as the market…
Read moreThe global cannabis industry saw an incredible end to 2024. Q4 2024 showed that the international medical cannabis explosion is…
Read moreExpanding its global footprint, SOMAÍ continues its European growth with a Swiss market entry through a strategic partnership with Dascoli…
Read moreMedical cannabis markets around the world are starting to show signs of early United States and Canadian-style progressions. Consumer flower…
Read more2025 is poised for a massive explosion in the global medical cannabis market. Many politicians and regulators have been grappling…
Read moreSOMAÍ Pharmaceuticals partnered with Pacific Cannovation Company Limited (PACCAN) to transform Thailand into a global hub for high-quality medicinal cannabis…
Read moreSOMAÍ Pharmaceuticals, a leading EU-GMP vertically integrated Multi-Country Operator (MCO) company, proudly announces the global launch of its Origins and…
Read moreCom uma das maiores infraestruturas para cultivo e produção de canábis, Portugal é o maior exportador europeu desta planta para…
Read moreAlthough new states continue to implement medical and adult-use cannabis programs, sales have been declining in the early adopters of…
Read moreGermany is one of the fastest-growing global medical cannabis markets. Recent changes in cannabis legislation have allowed doctors to more…
Read more